Search Results 3501-3510 of 22464 for oral
If subject is currently receiving oral aminosalicylate (including, but not limited to sulfasalazine or mesalamine), the subject is eligible provided the ...
antimicrobial use (oral or parenteral) is allowed. - Participants who require treatment with moderate or strong CYP3A inducers within 14 days prior to ...
... (oral, intravaginal, transdermal);; Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, implantable);; Placement ...
Use of any estrogen-containing medications with systemic absorption (such as oral contraceptives or hormonal replacement therapy) within 4 weeks prior to ...
2016. ModeratorConcurrent Oral Session, American Transplant Congress. 2015. Abstract ReviewerAmerican Transplant Congress. 2014 - 2018. MemberExecutive ...
Oral and Plastic Surgery and the Section of. Otolaryngology and Rhinology ... separate section of Laryngology, Oral and Plas- tic Surgery (Thomas J ...
The purpose of this study is to assess the safety/tolerability profile of E7386 as a single agent administered orally in participants with selected advanced ...
... (oral, intravaginal or transdermal); progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable or implantable); ...
Up to two regimens of therapy (conventional chemotherapy, antibody therapy, or an oral regimen) are allowed as long as a continuous response was ongoing ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.